Search results
Emcure Pharma IPO: Issue subscribed 29% on Day 1 so far; NIIs lead from the front
CNBC Awaaz· 5 days agoA day before the drugmaker's public offer went live, Emcure Pharmaceuticals raised Rs 582.6 crore...
Bain Capital-backed Emcure Pharma mobilises Rs 583 Cr from anchor investors
YourStory· 5 days agoThe anchor book includes HDFC Mutual Fund, ICICI Prudential MF, SBI MF, Nippon India MF, Abu Dhabi Investment Authority ...
Emcure Pharmaceuticals Raises Rs 582.6 Crore from Institutional Investors | India Infoline
India Infoline· 5 days agoPune-based Emcure Pharmaceuticals raises Rs 582.6 crore from institutional investors through an anchor book.
Emcure Pharma Backed By Bain Capital Mobilises ₹583 Crore From Anchor Investors
Free Press Journal· 5 days agoBain Capital-backed Emcure Pharmaceuticals on Tuesday said it has garnered Rs 583 crore from anchor...
Bain Capital-backed Emcure Pharma mobilises Rs 583 cr from anchor investors - ET HealthWorld |...
The Economic Times· 5 days agoEmcure Pharma: The pharma firm has decided to allot 57.8 lakh equity shares to 48 funds at Rs 1,008...
Chandigarh: Slain drug officer’s parents booked for forgery, cheating
Tribune India· 6 days agoThe parents of Neha Shoree, the Zonal Licensing Authority of the Food and Drug Administration,...
Bain Capital-backed Emcure Pharma mobilises Rs 583 cr from anchor investors
The Economic Times· 6 days agoEmcure Pharmaceuticals has allocated 57.8 lakh equity shares to 48 funds at the upper end of the IPO...
Emcure Pharmaceuticals raises Rs 583 crore from anchor investors ahead of IPO
CNBC Awaaz· 6 days agoEmcure Pharmaceuticals IPO | Marquee global investors including Abu Dhabi Investment Authority,...
Kotak Mutual Fund lifts investment restrictions in its smallcap fund
Business Standard India· 6 days agoKotak Mutual Fund has lifted investment restrictions on its smallcap fund, citing stability in the...
Kotak MF first to lift curbs on investing in small-cap fund
Livemint· 6 days agoThis move comes after a four-month hiatus aimed at curbing high valuations and limited investment...